Ekachai Medical Care Stock Price To Earnings To Growth
EKH Stock | THB 6.50 0.05 0.78% |
Ekachai Medical Care fundamentals help investors to digest information that contributes to Ekachai Medical's financial success or failures. It also enables traders to predict the movement of Ekachai Stock. The fundamental analysis module provides a way to measure Ekachai Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ekachai Medical stock.
Ekachai |
Ekachai Medical Care Company Price To Earnings To Growth Analysis
Ekachai Medical's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Ekachai Medical Care has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Providers & Services sector and about the same as Health Care (which currently averages 0.0) industry. The price to earnings to growth for all Thailand stocks is 100.0% higher than that of the company.
Ekachai Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ekachai Medical's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ekachai Medical could also be used in its relative valuation, which is a method of valuing Ekachai Medical by comparing valuation metrics of similar companies.Ekachai Medical is currently under evaluation in price to earnings to growth category among its peers.
Ekachai Fundamentals
Return On Equity | 0.23 | |||
Return On Asset | 0.12 | |||
Profit Margin | 0.27 % | |||
Operating Margin | 0.27 % | |||
Current Valuation | 5.05 B | |||
Shares Outstanding | 674.89 M | |||
Shares Owned By Insiders | 31.10 % | |||
Shares Owned By Institutions | 0.57 % | |||
Price To Earning | 50.32 X | |||
Price To Book | 3.80 X | |||
Price To Sales | 5.18 X | |||
Revenue | 1.15 B | |||
Gross Profit | 543.57 M | |||
EBITDA | 501.85 M | |||
Net Income | 344.83 M | |||
Cash And Equivalents | 237.21 M | |||
Cash Per Share | 0.40 X | |||
Total Debt | 35.15 M | |||
Debt To Equity | 0.04 % | |||
Current Ratio | 2.68 X | |||
Book Value Per Share | 2.24 X | |||
Cash Flow From Operations | 371.74 M | |||
Earnings Per Share | 0.44 X | |||
Target Price | 9.8 | |||
Number Of Employees | 26 | |||
Beta | 0.51 | |||
Market Capitalization | 6.07 B | |||
Total Asset | 1.33 B | |||
Annual Yield | 0.04 % | |||
Net Asset | 1.33 B | |||
Last Dividend Paid | 0.13 |
About Ekachai Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ekachai Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ekachai Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ekachai Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Ekachai Stock
Ekachai Medical financial ratios help investors to determine whether Ekachai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ekachai with respect to the benefits of owning Ekachai Medical security.